Immediate Breast Reconstruction in The Netherlands and the United States: A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data

Parisa Kamali, Annelotte C.M. van Bommel, Babette Becherer, Rodney Cooter, Marc A.M. Mureau, Andrea Pusic, Sabine Siesling, Rene J.W. van der Hulst, Samuel J. Lin, Hinne Rakhorst

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)

Abstract

Background: Studies based on large-volume databases have made significant contributions to research on breast cancer surgery. To date, no comparison between large-volume databases has been made internationally. This is the first proof-of-concept study exploring the feasibility of combining two existing operational databases of The Netherlands and the United States, focusing on breast cancer care and immediate breast reconstruction specifically.313/291

Methods: The National Breast Cancer Organization The Netherlands Breast Cancer Audit (NBCA) (2011 to 2015) and the U.S. Surveillance, Epidemiology, and End Results (SEER) database (2010 to 2013) were compared on structure and content. Data variables were grouped into general, treatment-specific, cancer-specific, and follow-up variables and were matched. As proof-of-concept, mastectomy and immediate breast reconstruction rates in patients diagnosed with invasive breast cancer or ductal carcinoma in situ were analyzed.

Results: The NBCA included 115 variables and SEER included 112. The NBCA included significantly more treatment-specific variables (n = 46 versus 6), whereas the SEER database included more cancer-specific variables (n = 74 versus 26). In patients diagnosed with breast cancer or ductal carcinoma in situ, immediate breast reconstruction was performed in 19.3 percent and 24.0 percent of the breast cancer cohort and 44.0 percent and 35.3 percent of the ductal carcinoma in situ cohort in the NBCA and SEER, respectively. Immediate breast reconstruction rates increased significantly over time in both data sets.

Conclusions: This study provides a first overview of available registry data on breast cancer care in The Netherlands and the United States, and revealed limited data on treatment in the United States. Comparison of treatment patterns of immediate breast reconstruction showed interesting differences. The authors advocate the urgency for an international database with alignment of (treatment) variables to improve quality of breast cancer care for patients across the globe.
Original languageEnglish
Pages (from-to)565-574
JournalPlastic and reconstructive surgery
Volume144
Issue number4
DOIs
Publication statusPublished - Oct 2019

Fingerprint

Mammaplasty
Quality of Health Care
Netherlands
Registries
Breast Neoplasms
Neoplasms
Databases
Carcinoma, Intraductal, Noninfiltrating
Epidemiology
Therapeutics
Mastectomy
Feasibility Studies
Patient Care

Cite this

Kamali, Parisa ; van Bommel, Annelotte C.M. ; Becherer, Babette ; Cooter, Rodney ; Mureau, Marc A.M. ; Pusic, Andrea ; Siesling, Sabine ; van der Hulst, Rene J.W. ; Lin, Samuel J. ; Rakhorst, Hinne. / Immediate Breast Reconstruction in The Netherlands and the United States : A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data. In: Plastic and reconstructive surgery. 2019 ; Vol. 144, No. 4. pp. 565-574.
@article{f62b0e4c95374fd0937eb3b5c010955f,
title = "Immediate Breast Reconstruction in The Netherlands and the United States: A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data",
abstract = "Background: Studies based on large-volume databases have made significant contributions to research on breast cancer surgery. To date, no comparison between large-volume databases has been made internationally. This is the first proof-of-concept study exploring the feasibility of combining two existing operational databases of The Netherlands and the United States, focusing on breast cancer care and immediate breast reconstruction specifically.313/291Methods: The National Breast Cancer Organization The Netherlands Breast Cancer Audit (NBCA) (2011 to 2015) and the U.S. Surveillance, Epidemiology, and End Results (SEER) database (2010 to 2013) were compared on structure and content. Data variables were grouped into general, treatment-specific, cancer-specific, and follow-up variables and were matched. As proof-of-concept, mastectomy and immediate breast reconstruction rates in patients diagnosed with invasive breast cancer or ductal carcinoma in situ were analyzed.Results: The NBCA included 115 variables and SEER included 112. The NBCA included significantly more treatment-specific variables (n = 46 versus 6), whereas the SEER database included more cancer-specific variables (n = 74 versus 26). In patients diagnosed with breast cancer or ductal carcinoma in situ, immediate breast reconstruction was performed in 19.3 percent and 24.0 percent of the breast cancer cohort and 44.0 percent and 35.3 percent of the ductal carcinoma in situ cohort in the NBCA and SEER, respectively. Immediate breast reconstruction rates increased significantly over time in both data sets.Conclusions: This study provides a first overview of available registry data on breast cancer care in The Netherlands and the United States, and revealed limited data on treatment in the United States. Comparison of treatment patterns of immediate breast reconstruction showed interesting differences. The authors advocate the urgency for an international database with alignment of (treatment) variables to improve quality of breast cancer care for patients across the globe.",
author = "Parisa Kamali and {van Bommel}, {Annelotte C.M.} and Babette Becherer and Rodney Cooter and Mureau, {Marc A.M.} and Andrea Pusic and Sabine Siesling and {van der Hulst}, {Rene J.W.} and Lin, {Samuel J.} and Hinne Rakhorst",
year = "2019",
month = "10",
doi = "10.1097/PRS.0000000000006011",
language = "English",
volume = "144",
pages = "565--574",
journal = "Plastic and reconstructive surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Immediate Breast Reconstruction in The Netherlands and the United States : A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data. / Kamali, Parisa; van Bommel, Annelotte C.M.; Becherer, Babette; Cooter, Rodney; Mureau, Marc A.M.; Pusic, Andrea; Siesling, Sabine ; van der Hulst, Rene J.W.; Lin, Samuel J.; Rakhorst, Hinne.

In: Plastic and reconstructive surgery, Vol. 144, No. 4, 10.2019, p. 565-574.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Immediate Breast Reconstruction in The Netherlands and the United States

T2 - A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data

AU - Kamali, Parisa

AU - van Bommel, Annelotte C.M.

AU - Becherer, Babette

AU - Cooter, Rodney

AU - Mureau, Marc A.M.

AU - Pusic, Andrea

AU - Siesling, Sabine

AU - van der Hulst, Rene J.W.

AU - Lin, Samuel J.

AU - Rakhorst, Hinne

PY - 2019/10

Y1 - 2019/10

N2 - Background: Studies based on large-volume databases have made significant contributions to research on breast cancer surgery. To date, no comparison between large-volume databases has been made internationally. This is the first proof-of-concept study exploring the feasibility of combining two existing operational databases of The Netherlands and the United States, focusing on breast cancer care and immediate breast reconstruction specifically.313/291Methods: The National Breast Cancer Organization The Netherlands Breast Cancer Audit (NBCA) (2011 to 2015) and the U.S. Surveillance, Epidemiology, and End Results (SEER) database (2010 to 2013) were compared on structure and content. Data variables were grouped into general, treatment-specific, cancer-specific, and follow-up variables and were matched. As proof-of-concept, mastectomy and immediate breast reconstruction rates in patients diagnosed with invasive breast cancer or ductal carcinoma in situ were analyzed.Results: The NBCA included 115 variables and SEER included 112. The NBCA included significantly more treatment-specific variables (n = 46 versus 6), whereas the SEER database included more cancer-specific variables (n = 74 versus 26). In patients diagnosed with breast cancer or ductal carcinoma in situ, immediate breast reconstruction was performed in 19.3 percent and 24.0 percent of the breast cancer cohort and 44.0 percent and 35.3 percent of the ductal carcinoma in situ cohort in the NBCA and SEER, respectively. Immediate breast reconstruction rates increased significantly over time in both data sets.Conclusions: This study provides a first overview of available registry data on breast cancer care in The Netherlands and the United States, and revealed limited data on treatment in the United States. Comparison of treatment patterns of immediate breast reconstruction showed interesting differences. The authors advocate the urgency for an international database with alignment of (treatment) variables to improve quality of breast cancer care for patients across the globe.

AB - Background: Studies based on large-volume databases have made significant contributions to research on breast cancer surgery. To date, no comparison between large-volume databases has been made internationally. This is the first proof-of-concept study exploring the feasibility of combining two existing operational databases of The Netherlands and the United States, focusing on breast cancer care and immediate breast reconstruction specifically.313/291Methods: The National Breast Cancer Organization The Netherlands Breast Cancer Audit (NBCA) (2011 to 2015) and the U.S. Surveillance, Epidemiology, and End Results (SEER) database (2010 to 2013) were compared on structure and content. Data variables were grouped into general, treatment-specific, cancer-specific, and follow-up variables and were matched. As proof-of-concept, mastectomy and immediate breast reconstruction rates in patients diagnosed with invasive breast cancer or ductal carcinoma in situ were analyzed.Results: The NBCA included 115 variables and SEER included 112. The NBCA included significantly more treatment-specific variables (n = 46 versus 6), whereas the SEER database included more cancer-specific variables (n = 74 versus 26). In patients diagnosed with breast cancer or ductal carcinoma in situ, immediate breast reconstruction was performed in 19.3 percent and 24.0 percent of the breast cancer cohort and 44.0 percent and 35.3 percent of the ductal carcinoma in situ cohort in the NBCA and SEER, respectively. Immediate breast reconstruction rates increased significantly over time in both data sets.Conclusions: This study provides a first overview of available registry data on breast cancer care in The Netherlands and the United States, and revealed limited data on treatment in the United States. Comparison of treatment patterns of immediate breast reconstruction showed interesting differences. The authors advocate the urgency for an international database with alignment of (treatment) variables to improve quality of breast cancer care for patients across the globe.

U2 - 10.1097/PRS.0000000000006011

DO - 10.1097/PRS.0000000000006011

M3 - Article

VL - 144

SP - 565

EP - 574

JO - Plastic and reconstructive surgery

JF - Plastic and reconstructive surgery

SN - 0032-1052

IS - 4

ER -